title: Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes.
abstract: We screened 71 sporadic and 7 familial Rett syndrome (RTT) patients for MECP2 mutations by direct sequencing and determined the pattern of X chromosome inactivation (XCI) in 39 RTT patients. We identified 23 different disease-causing MECP2 mutations in 54 of 71 (76%) sporadic patients and in 2 of 7 (29%) familial cases. We compared electrophysiological findings, cerebrospinal fluid neurochemistry, and 13 clinical characteristics between patients carrying missense mutations and those carrying truncating mutations. Thirty-one of 34 patients (91%) with classic RTT had random XCI. Nonrandom XCI was associated with milder phenotypes, including a mitigated classic RTT caused by a rare early truncating mutation. Patients with truncating mutations have a higher incidence of awake respiratory dysfunction and lower levels of cerebrospinal fluid homovanillic acid. Scoliosis is more common in patients with missense mutations. These data indicate that different MECP2 mutations have similar phenotypic consequences, and random XCI plays an important role in producing the full phenotypic spectrum of classic RTT. The association of early truncating mutations with nonrandom XCI, along with the fact that chimeric mice lacking methyl-CpG-binding protein 2 (MeCP2) function die during embryogenesis, supports the notion that RTT is caused by partial loss of MeCP2 function.
authors.affiliation: Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
authors.forename: R E
authors.initials: RE
authors.lastname: Amir
authors.forename: I B
authors.initials: IB
authors.lastname: Van den Veyver
authors.forename: R
authors.initials: R
authors.lastname: Schultz
authors.forename: D M
authors.initials: DM
authors.lastname: Malicki
authors.forename: C Q
authors.initials: CQ
authors.lastname: Tran
authors.forename: E J
authors.initials: EJ
authors.lastname: Dahle
authors.forename: A
authors.initials: A
authors.lastname: Philippi
authors.forename: L
authors.initials: L
authors.lastname: Timar
authors.forename: A K
authors.initials: AK
authors.lastname: Percy
authors.forename: K J
authors.initials: KJ
authors.lastname: Motil
authors.forename: O
authors.initials: O
authors.lastname: Lichtarge
authors.forename: E O
authors.initials: EO
authors.lastname: Smith
authors.forename: D G
authors.initials: DG
authors.lastname: Glaze
authors.forename: H Y
authors.initials: HY
authors.lastname: Zoghbi
mesh_terms: D004252:DNA Mutational Analysis; D004268:DNA-Binding Proteins / Q000235:genetics*; D004303:Dosage Compensation, Genetic; D004594:Electrophysiology / Q000379:methods; D015870:Gene Expression / Q000235:genetics*; D006801:Humans; D007223:Infant; D020125:Mutation, Missense / Q000235:genetics; D010375:Pedigree; D010641:Phenotype; D017354:Point Mutation / Q000235:genetics*; D015518:Rett Syndrome / Q000235:genetics*; D012720:Severity of Illness Index; D014960:X Chromosome / Q000235:genetics*
chemical_list: D004268:DNA-Binding Proteins